Pafford has rolled out a Low Titer O whole-blood program for EMS across western Oklahoma, and a May 6 blood drive at its OKC headquarters seeks Type O donors.

Clinton‑Sherman Industrial Airpark has been rebranded Infinity One as Oklahoma courts suborbital launches and Dawn Aerospace eyes Burns Flat for 2027 flights. State officials point to a 13,503‑foot runway and industrial park to sell the site to aerospace tenants.

OU College of Pharmacy is building a cyclotron on the OU Health campus to produce PET radiopharmaceuticals in‑state, aiming to cut travel and speed access to advanced imaging and therapies.

Lawton installs a Naloxone vending machine for opioid overdose prevention, offering free access to the public without prescription or ID, funded by the Oklahoma Opioid Abatement Grant.

Dr. Ruiqing Shen of Oklahoma State University is developing thermoresponsive hydrogels for efficient firefighting, focusing on wildland and lithium-ion battery fires. The NSF-funded research aims to create less water-dependent fire retardants.

Dr. Masapollo researches how children with hearing loss learn to speak using tactile feedback, potentially improving speech therapy by emphasizing touch over sound.

Dong Zhang of the University of Oklahoma received an NSF CAREER Award and a $556,000 grant to enhance EV battery technology, focusing on computational modeling to address lithium-ion batteries' energy density and longevity.

University of Oklahoma researchers uncover new details about the hormone amylin's function, influencing obesity drug development by understanding amylin receptor dynamics.

OSU joins Google AI for Education Accelerator, providing students with AI training, free Google Career Certificates, and support for job readiness, enhancing Oklahoma's workforce.

NobleReach™ Foundation will send three 2025 Scholars to the Oklahoma City Office of Innovation to aid in technological development using their data science and business innovation skills.

Researchers at the University of Oklahoma have found that gut bacteria produce toxins that can selectively attack cancer cells, offering a new potential strategy for treating cancer.

University of Oklahoma researchers collaborate with Xironetic, using augmented reality for neurosurgical procedures to improve patient safety and training.

Scientists from the University of Oklahoma discovered that the hormone FGF21 may reverse fatty liver disease by signaling the brain to initiate liver repair, a finding that may lead to new treatments.